INCOME TAXES (Tables)
|
12 Months Ended |
Jun. 30, 2025 |
Income Tax Disclosure [Abstract] |
|
Schedule of Components of Income Tax Expense on Continuing Operations |
Significant components of consolidated income tax expense on continuing operations were as follows (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended June 30, | | 2025 | | 2024 | | 2023 | Current: | | | | | | Federal | $ | (1,258) | | | $ | 131,548 | | | $ | 673 | | State | (503) | | | 34,030 | | | 3,016 | | Total current tax (benefit) expense | (1,761) | | | 165,578 | | | 3,689 | | Deferred: | | | | | | Federal | 24,290 | | | (104,194) | | | 55,137 | | State | 2,785 | | | (19,082) | | | 17,257 | | Total deferred tax expense (benefit) | 27,076 | | | (123,276) | | | 72,394 | | Total income tax expense | $ | 25,315 | | | $ | 42,302 | | | $ | 76,083 | |
|
Schedule of Effective Income Tax Rate Reconciliation |
Reconciliations between the Company’s income tax expense and taxes computed at the federal statutory tax rate of 21.0% for fiscal years ended June 30, 2025, 2024, and 2023 were as follows (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended June 30, | | 2025 | | 2024 | | 2023 | Tax at federal statutory rate | $ | 20,682 | | | $ | 32,005 | | | $ | 51,658 | | Partnership (income) loss not subject to tax | (2,481) | | | 3,297 | | | 47 | | State taxes (net of federal benefit) | 4,020 | | | 7,084 | | | 11,212 | | Remeasurement adjustments and other permanent items | 9,755 | | | 3,110 | | | 4,628 | | Change in valuation allowance | (3,849) | | | 771 | | | 52 | | Deferred tax remeasurement | 359 | | | (319) | | | 7,720 | | Uncertain tax position | (1,495) | | | 310 | | | 1,092 | | Research and development credit | (3,743) | | | (4,549) | | | (2,343) | | Other | 2,067 | | | 593 | | | 2,017 | | Total income tax expense | $ | 25,315 | | | $ | 42,302 | | | $ | 76,083 | | Effective tax rate | 25.7 % | | 28.9 % | | 30.2 % |
|
Schedule of Deferred Tax Assets and Liabilities |
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of June 30, 2025 and 2024 were as follows (in thousands): | | | | | | | | | | | | | June 30, | | 2025 | | 2024 | Deferred tax assets | | | | | | | | Purchased intangible assets and depreciation | $ | 446,728 | | | $ | 496,174 | | Stock compensation | 5,508 | | | 7,756 | | Accrued expenses | 75,161 | | | 55,186 | | Net operating losses and credits | 59,925 | | | 30,955 | | Sale of member contracts and associated future revenues to OMNIA | 161,353 | | | 162,992 | | Partnership basis differences | 20,463 | | | 45,447 | | Other | 16,531 | | | 7,013 | | Total deferred tax assets | 785,669 | | | 805,523 | | Valuation allowance for deferred tax assets | (711) | | | (5,375) | | Deferred tax assets, net of valuation allowance | 784,958 | | | 800,148 | | Deferred tax liabilities | | | | Equity earnings | (15,519) | | | (20,738) | | Other liabilities | (6,580) | | | (6,408) | | Net deferred tax assets | $ | 762,859 | | | $ | 773,002 | |
|
Schedule of Unrecognized Tax Benefits |
Reconciliations of the beginning and ending gross amounts of the Company’s uncertain tax position reserves for the years ended June 30, 2025, 2024, and 2023 were as follows (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended June 30, | | 2025 | | 2024 | | 2023 | Beginning of year balance | $ | 16,602 | | | $ | 16,912 | | | $ | 17,124 | | Increases in prior period tax positions | — | | | 316 | | | 189 | | Decreases in prior period tax positions | (2,174) | | | (1,308) | | | (752) | | Reductions on settlements and lapse in statute of limitations | — | | | (16) | | | (16) | | Increases in current period tax positions | 1,039 | | | 698 | | | 367 | | End of year balance | $ | 15,467 | | | $ | 16,602 | | | $ | 16,912 | |
|